HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Verna Cázares-Ordoñez Selected Research

PF 00477736

1/2020CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Verna Cázares-Ordoñez Research Topics

Disease

3Neoplasms (Cancer)
02/2022 - 09/2014
2Neuroblastoma
02/2022 - 01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2015

Drug/Important Bio-Agent (IBA)

2MicroRNAs (MicroRNA)IBA
08/2015 - 09/2014
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1Messenger RNA (mRNA)IBA
02/2022
1PF 00477736IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Cholecalciferol (Vitamin D3)FDA Link
08/2015
1Calcitriol (Calcijex)FDA LinkGeneric
08/2015
1Hormones (Hormone)IBA
09/2014
1SteroidsIBA
09/2014